HUMAN EHRLICHIOSIS

This adverse event was reported 209 times

HUMAN EHRLICHIOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN 2 0.0041
1 VALGANCICLOVIR 49 0.0026
2 BASILIXIMAB 22 0.0018
3 VANCOMYCIN HYDROCHLORIDE 15 0.0018
4 SIROLIMUS 19 0.0014
5 MYCOPHENILIC ACID 24 0.0011
6 OMEPRAZOLE 20MG 1 0.0009
7 MYCOPHENOLIC ACID 28 0.0009
8 AMPICILLIN INJECTION 6 0.0008
9 TACROLIMUS OINTMENT 0.1% 95 0.0007
See all drugs enriched for association with HUMAN EHRLICHIOSIS